Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors 14 Junij 2013Press releaseHumanPharmacovigilance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013 14 Junij 2013NewsHumanPharmacovigilance Revised guideline on biosimilars containing biotechnology-derived proteins published for public consultation 10 Junij 2013NewsHumanBiosimilarsRegulatory and procedural guidance European Medicines Agency publishes interim fee advice for bluetongue-vaccine manufacturers 7 Junij 2013NewsCorporateMedicines Public consultation open on guideline on the acceptability of names for human medicines 7 Junij 2013NewsCorporateRegulatory and procedural guidance Comments invited on good-pharmacovigilance-practice module on reporting of adverse reactions 7 Junij 2013NewsCorporate European Medicines Agency and EUnetHTA review progress of their cooperation 7 Junij 2013Press releaseCorporateMedicines Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders 5 Junij 2013NewsCorporate Revised version of application form for initial evaluation of human medicines available 3 Junij 2013NewsCorporate European Medicines Agency recommends approval of pomalidomide for the treatment of multiple myeloma 31 Maj 2013Press releaseHumanMedicines 1 … 226 227 228 229 230 Page 230 of 384 231 232 233 234 … 384
PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors 14 Junij 2013Press releaseHumanPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013 14 Junij 2013NewsHumanPharmacovigilance
Revised guideline on biosimilars containing biotechnology-derived proteins published for public consultation 10 Junij 2013NewsHumanBiosimilarsRegulatory and procedural guidance
European Medicines Agency publishes interim fee advice for bluetongue-vaccine manufacturers 7 Junij 2013NewsCorporateMedicines
Public consultation open on guideline on the acceptability of names for human medicines 7 Junij 2013NewsCorporateRegulatory and procedural guidance
Comments invited on good-pharmacovigilance-practice module on reporting of adverse reactions 7 Junij 2013NewsCorporate
European Medicines Agency and EUnetHTA review progress of their cooperation 7 Junij 2013Press releaseCorporateMedicines
Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders 5 Junij 2013NewsCorporate
Revised version of application form for initial evaluation of human medicines available 3 Junij 2013NewsCorporate
European Medicines Agency recommends approval of pomalidomide for the treatment of multiple myeloma 31 Maj 2013Press releaseHumanMedicines